92 related articles for article (PubMed ID: 19854303)
1. Manipulation of process parameters to achieve different ternary phase microparticle configurations.
Lee WL; Foo WL; Widjaja E; Loo SC
Acta Biomater; 2010 Apr; 6(4):1342-52. PubMed ID: 19854303
[TBL] [Abstract][Full Text] [Related]
2. Altering the drug release profiles of double-layered ternary-phase microparticles.
Lee WL; Loei C; Widjaja E; Loo SC
J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
Pollauf EJ; Kim KK; Pack DW
J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
[TBL] [Abstract][Full Text] [Related]
4. Fabrication and drug release study of double-layered microparticles of various sizes.
Lee WL; Seh YC; Widjaja E; Chong HC; Tan NS; Loo SC
J Pharm Sci; 2012 Aug; 101(8):2787-97. PubMed ID: 22573569
[TBL] [Abstract][Full Text] [Related]
5. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
6. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).
Ghaderi R; Artursson P; Carlfors J
Pharm Res; 1999 May; 16(5):676-81. PubMed ID: 10350010
[TBL] [Abstract][Full Text] [Related]
7. Partial solubility parameters of poly(D,L-lactide-co-glycolide).
Schenderlein S; Lück M; Müller BW
Int J Pharm; 2004 Nov; 286(1-2):19-26. PubMed ID: 15500999
[TBL] [Abstract][Full Text] [Related]
8. Designing multilayered particulate systems for tunable drug release profiles.
Lee WL; Yu PO; Hong M; Widjaja E; Loo SC
Acta Biomater; 2012 Jul; 8(6):2271-8. PubMed ID: 22342827
[TBL] [Abstract][Full Text] [Related]
9. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
[TBL] [Abstract][Full Text] [Related]
10. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
12. One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system.
Lee WL; Widjaja E; Loo SC
Small; 2010 May; 6(9):1003-11. PubMed ID: 20358528
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
Xinteng Z; Weisan P; Ruhua Z; Feng Z
Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
[TBL] [Abstract][Full Text] [Related]
14. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyapatite/biodegradable poly(L-lactide-co-ε-caprolactone) composite microparticles as injectable scaffolds by a Pickering emulsion route.
Liu X; Okada M; Maeda H; Fujii S; Furuzono T
Acta Biomater; 2011 Feb; 7(2):821-8. PubMed ID: 20807593
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of double-walled microparticles prepared with a modified water-in-oil-in-oil-in-water (w1/o/o/w3) method.
Devrim B; Bozkır A
J Microencapsul; 2013; 30(8):741-54. PubMed ID: 23631379
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication.
Katou H; Wandrey AJ; Gander B
Int J Pharm; 2008 Nov; 364(1):45-53. PubMed ID: 18782610
[TBL] [Abstract][Full Text] [Related]
18. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying.
Clarke N; O'Connor K; Ramtoola Z
Drug Dev Ind Pharm; 1998 Feb; 24(2):169-74. PubMed ID: 15605447
[TBL] [Abstract][Full Text] [Related]
19. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
[TBL] [Abstract][Full Text] [Related]
20. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
